Clinical Trial Update: Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN) [Phase 2]

View source ↗

Summary

A Phase 2 trial of SOR007 Ointment for cervical intraepithelial neoplasia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• SOR007 Ointment (SOR007)

Snippet

Sponsor: DFB Soria, LLC | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: WITHDRAWN